Video

Dr. Alexander Kretschmer on clinical interpretation of the ExoDx Prostate test

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Dr. Alexander Kretschmer, MD, discusses the clinical interpretation and value of the ExoDx Prostate test (EPI test). The non-invasive, urine-based genomic test is a risk assessment tool that helps physicians and patients determine whether a prostate biopsy is necessary when PSA screening provides an ambiguous result.

      Kretschmer is an assistant professor of Urology at Ludwig-Maximilians-University Munich.

      © 2025 MJH Life Sciences

      All rights reserved.